m⁶A regulator-based methylation modification patterns characterized by distinct tumor microenvironment immune profiles in colon cancer

Wei Chong, Liang Shang, Jin Liu, +10

Theranostics

Association of LRP1B Mutation With Tumor Mutation Burden and Outcomes in Melanoma and Non-small Cell Lung Cancer Patients Treated With Immune Check-Point Blockades

Hao Chen, Wei Chong, Qian Wu, +3

Frontiers in Immunology

The immune response‐related mutational signatures and driver genes in non‐small‐cell lung cancer

Hao Chen, Wei Chong, Changcai Teng, +3

Cancer Science

Identification of an Immune Signature Predicting Prognosis Risk and Lymphocyte Infiltration in Colon Cancer

Xinyu Li, Dacheng Wen, Xiaokang Li, +3

Frontiers in Immunology

Micropeptide PACMP inhibition elicits synthetic lethal effects by decreasing CtIP and poly(ADP-ribosyl)ation

Chuanchao Zhang, Bo Zhou, Feng Gu, +19

Molecular Cell

Integrated multi-omics characterization of KRAS mutant colorectal cancer

Wei Chong, Xingyu Zhu, Huicheng Ren, +7

Theranostics

Association of clock-like mutational signature with immune checkpoint inhibitor outcome in patients with melanoma and NSCLC

Wei Chong, Zhe Wang, Liang Shang, +8

Molecular Therapy — Nucleic Acids

Malignancy without immortality? Cellular immortalization as a possible late event in melanoma progression

Julia K. Soo, Alastair D. MacKenzie Ross, David Kallenberg, +10

Pigment Cell & Melanoma Research

Aquaporin 1 promotes sensitivity of anthracycline chemotherapy in breast cancer by inhibiting β-catenin degradation to enhance TopoIIα activity

Wei Chong, Huikun Zhang, Zhifang Guo, +10

Cell Death and Differentiation

Age-related mutational signature negatively associated with immune activity and survival outcome in triple-negative breast cancer

Hao Chen, Wei Chong, Xiaorong Yang, +4

OncoImmunology